Start the conversation
From March 20 through March 26, the Nasdaq biotech index dipped 7%. The S&P biotech index dropped almost 11%. Nasdaq stocks fell 3.2% on the week after a hot start to 2015 where the index was up 6.1% and eclipsed the 5,000 mark for the first time since 2000. iShares NASDAQ Biotechnology Index ETF (Nasdaq: IBB) was down 3.9% last week, though was up 14.5% for the quarter.
But even for all the bears screaming "biotech bubble" right now, don’t go sour on biotech stocks just because of this slight aberration in the markets. If anything, use this opportunity to buy quality stocks on the dips.